Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Monoclonal antibodies are a special type of antibody that is created in the laboratory to find and destroy a specific target, in this case cancer. Because of their accuracy, it is desirable to treat tumors with monoclonal antibodies more specifically than chemotherapeutic drugs, and therefore with fewer side effects. In health care, cancer is one of the biggest concerns. Therefore, monoclonal antibodies are increasingly used to treat cancer.
North America is expected to hold a significant share in the Cancer Monoclonal Antibodies market. The cancer monoclonal antibodies market is expected to witness a CAGR of 10% during the forecast period, 2020-2026.
The growing prevalence of cancer, increasing investment in R&D of genomic studies, and rising advancements in the specificity of monoclonal antibodies to target cancer are the factors to drive the Cancer Monoclonal Antibodies market. However, long duration of research and development before clinical trials and the rise in the failures of mAbs in clinical trials may hinder the growth of the cancer monoclonal antibodies market.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Cancer Monoclonal Antibodies market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Cancer Monoclonal Antibodies market. Detailed analysis of key players, along with key growth strategies adopted by Cancer Monoclonal Antibodies industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Takeda Pharmaceuticals
Bristol-Myers Squibb
Amgen
F Hoffmann-La Roche
By Type:
Murine Antibodies
Chimeric and Humanised Antibodies
Fully Humanized Antibodies
Others
By End-User:
Breast Cancer
Blood Cancer
Liver Cancer
Brain Cancer
Colorectal Cancer
Other Applications
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Cancer Monoclonal Antibodies Market
-
1.3 Market Segment by Type
-
1.3.1 China Cancer Monoclonal Antibodies Market Size and Growth Rate of Murine Antibodies from 2016 to 2027
-
1.3.2 China Cancer Monoclonal Antibodies Market Size and Growth Rate of Chimeric and Humanised Antibodies from 2016 to 2027
-
1.3.3 China Cancer Monoclonal Antibodies Market Size and Growth Rate of Fully Humanized Antibodies from 2016 to 2027
-
1.3.4 China Cancer Monoclonal Antibodies Market Size and Growth Rate of Others from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Cancer Monoclonal Antibodies Market Size and Growth Rate of Breast Cancer from 2016 to 2027
-
1.4.2 China Cancer Monoclonal Antibodies Market Size and Growth Rate of Blood Cancer from 2016 to 2027
-
1.4.3 China Cancer Monoclonal Antibodies Market Size and Growth Rate of Liver Cancer from 2016 to 2027
-
1.4.4 China Cancer Monoclonal Antibodies Market Size and Growth Rate of Brain Cancer from 2016 to 2027
-
1.4.5 China Cancer Monoclonal Antibodies Market Size and Growth Rate of Colorectal Cancer from 2016 to 2027
-
1.4.6 China Cancer Monoclonal Antibodies Market Size and Growth Rate of Other Applications from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Cancer Monoclonal Antibodies Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Cancer Monoclonal Antibodies Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Cancer Monoclonal Antibodies Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Cancer Monoclonal Antibodies Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Cancer Monoclonal Antibodies Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Cancer Monoclonal Antibodies Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Cancer Monoclonal Antibodies Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Cancer Monoclonal Antibodies Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Cancer Monoclonal Antibodies by Major Types
-
3.4.1 Market Size and Growth Rate of Murine Antibodies
-
3.4.2 Market Size and Growth Rate of Chimeric and Humanised Antibodies
-
3.4.3 Market Size and Growth Rate of Fully Humanized Antibodies
-
3.4.4 Market Size and Growth Rate of Others
4 Segmentation of Cancer Monoclonal Antibodies Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Cancer Monoclonal Antibodies by Major End-Users
-
4.4.1 Market Size and Growth Rate of Cancer Monoclonal Antibodies in Breast Cancer
-
4.4.2 Market Size and Growth Rate of Cancer Monoclonal Antibodies in Blood Cancer
-
4.4.3 Market Size and Growth Rate of Cancer Monoclonal Antibodies in Liver Cancer
-
4.4.4 Market Size and Growth Rate of Cancer Monoclonal Antibodies in Brain Cancer
-
4.4.5 Market Size and Growth Rate of Cancer Monoclonal Antibodies in Colorectal Cancer
-
4.4.6 Market Size and Growth Rate of Cancer Monoclonal Antibodies in Other Applications
5 Market Analysis by Regions
-
5.1 China Cancer Monoclonal Antibodies Production Analysis by Regions
-
5.2 China Cancer Monoclonal Antibodies Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Cancer Monoclonal Antibodies Landscape Analysis
-
6.1 North China Cancer Monoclonal Antibodies Landscape Analysis by Major Types
-
6.2 North China Cancer Monoclonal Antibodies Landscape Analysis by Major End-Users
7 Central China Cancer Monoclonal Antibodies Landscape Analysis
-
7.1 Central China Cancer Monoclonal Antibodies Landscape Analysis by Major Types
-
7.2 Central China Cancer Monoclonal Antibodies Landscape Analysis by Major End-Users
8 South China Cancer Monoclonal Antibodies Landscape Analysis
-
8.1 South China Cancer Monoclonal Antibodies Landscape Analysis by Major Types
-
8.2 South China Cancer Monoclonal Antibodies Landscape Analysis by Major End-Users
9 East China Cancer Monoclonal Antibodies Landscape Analysis
-
9.1 East China Cancer Monoclonal Antibodies Landscape Analysis by Major Types
-
9.2 East China Cancer Monoclonal Antibodies Landscape Analysis by Major End-Users
10 Northeast China Cancer Monoclonal Antibodies Landscape Analysis
-
10.1 Northeast China Cancer Monoclonal Antibodies Landscape Analysis by Major Types
-
10.2 Northeast China Cancer Monoclonal Antibodies Landscape Analysis by Major End-Users
11 Southwest China Cancer Monoclonal Antibodies Landscape Analysis
-
11.1 Southwest China Cancer Monoclonal Antibodies Landscape Analysis by Major Types
-
11.2 Southwest China Cancer Monoclonal Antibodies Landscape Analysis by Major End-Users
12 Northwest China Cancer Monoclonal Antibodies Landscape Analysis
-
12.1 Northwest China Cancer Monoclonal Antibodies Landscape Analysis by Major Types
-
12.2 Northwest China Cancer Monoclonal Antibodies Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Takeda Pharmaceuticals
-
13.1.1 Takeda Pharmaceuticals Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Bristol-Myers Squibb
-
13.2.1 Bristol-Myers Squibb Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Amgen
-
13.3.1 Amgen Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 F Hoffmann-La Roche
-
13.4.1 F Hoffmann-La Roche Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Cancer Monoclonal Antibodies Market Size and Growth Rate of Murine Antibodies from 2016 to 2027
-
Figure China Cancer Monoclonal Antibodies Market Size and Growth Rate of Chimeric and Humanised Antibodies from 2016 to 2027
-
Figure China Cancer Monoclonal Antibodies Market Size and Growth Rate of Fully Humanized Antibodies from 2016 to 2027
-
Figure China Cancer Monoclonal Antibodies Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Cancer Monoclonal Antibodies Market Size and Growth Rate of Breast Cancer from 2016 to 2027
-
Figure China Cancer Monoclonal Antibodies Market Size and Growth Rate of Blood Cancer from 2016 to 2027
-
Figure China Cancer Monoclonal Antibodies Market Size and Growth Rate of Liver Cancer from 2016 to 2027
-
Figure China Cancer Monoclonal Antibodies Market Size and Growth Rate of Brain Cancer from 2016 to 2027
-
Figure China Cancer Monoclonal Antibodies Market Size and Growth Rate of Colorectal Cancer from 2016 to 2027
-
Figure China Cancer Monoclonal Antibodies Market Size and Growth Rate of Other Applications from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Cancer Monoclonal Antibodies Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Cancer Monoclonal Antibodies Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Cancer Monoclonal Antibodies Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Cancer Monoclonal Antibodies Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Cancer Monoclonal Antibodies Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Cancer Monoclonal Antibodies Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Cancer Monoclonal Antibodies Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Cancer Monoclonal Antibodies Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Cancer Monoclonal Antibodies
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Cancer Monoclonal Antibodies by Different Types from 2016 to 2027
-
Table Consumption Share of Cancer Monoclonal Antibodies by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Murine Antibodies
-
Figure Market Size and Growth Rate of Chimeric and Humanised Antibodies
-
Figure Market Size and Growth Rate of Fully Humanized Antibodies
-
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Cancer Monoclonal Antibodies by Different End-Users from 2016 to 2027
-
Table Consumption Share of Cancer Monoclonal Antibodies by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Breast Cancer
-
Figure Market Size and Growth Rate of Blood Cancer
-
Figure Market Size and Growth Rate of Liver Cancer
-
Figure Market Size and Growth Rate of Brain Cancer
-
Figure Market Size and Growth Rate of Colorectal Cancer
-
Figure Market Size and Growth Rate of Other Applications
-
Table China Cancer Monoclonal Antibodies Production by Regions
-
Table China Cancer Monoclonal Antibodies Production Share by Regions
-
Figure China Cancer Monoclonal Antibodies Production Share by Regions in 2016
-
Figure China Cancer Monoclonal Antibodies Production Share by Regions in 2021
-
Figure China Cancer Monoclonal Antibodies Production Share by Regions in 2027
-
Table China Cancer Monoclonal Antibodies Consumption by Regions
-
Table China Cancer Monoclonal Antibodies Consumption Share by Regions
-
Figure China Cancer Monoclonal Antibodies Consumption Share by Regions in 2016
-
Figure China Cancer Monoclonal Antibodies Consumption Share by Regions in 2021
-
Figure China Cancer Monoclonal Antibodies Consumption Share by Regions in 2027
-
Table North China Cancer Monoclonal Antibodies Consumption by Types from 2016 to 2027
-
Table North China Cancer Monoclonal Antibodies Consumption Share by Types from 2016 to 2027
-
Figure North China Cancer Monoclonal Antibodies Consumption Share by Types in 2016
-
Figure North China Cancer Monoclonal Antibodies Consumption Share by Types in 2021
-
Figure North China Cancer Monoclonal Antibodies Consumption Share by Types in 2027
-
Table North China Cancer Monoclonal Antibodies Consumption by End-Users from 2016 to 2027
-
Table North China Cancer Monoclonal Antibodies Consumption Share by End-Users from 2016 to 2027
-
Figure North China Cancer Monoclonal Antibodies Consumption Share by End-Users in 2016
-
Figure North China Cancer Monoclonal Antibodies Consumption Share by End-Users in 2021
-
Figure North China Cancer Monoclonal Antibodies Consumption Share by End-Users in 2027
-
Table Central China Cancer Monoclonal Antibodies Consumption by Types from 2016 to 2027
-
Table Central China Cancer Monoclonal Antibodies Consumption Share by Types from 2016 to 2027
-
Figure Central China Cancer Monoclonal Antibodies Consumption Share by Types in 2016
-
Figure Central China Cancer Monoclonal Antibodies Consumption Share by Types in 2021
-
Figure Central China Cancer Monoclonal Antibodies Consumption Share by Types in 2027
-
Table Central China Cancer Monoclonal Antibodies Consumption by End-Users from 2016 to 2027
-
Table Central China Cancer Monoclonal Antibodies Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Cancer Monoclonal Antibodies Consumption Share by End-Users in 2016
-
Figure Central China Cancer Monoclonal Antibodies Consumption Share by End-Users in 2021
-
Figure Central China Cancer Monoclonal Antibodies Consumption Share by End-Users in 2027
-
Table South China Cancer Monoclonal Antibodies Consumption by Types from 2016 to 2027
-
Table South China Cancer Monoclonal Antibodies Consumption Share by Types from 2016 to 2027
-
Figure South China Cancer Monoclonal Antibodies Consumption Share by Types in 2016
-
Figure South China Cancer Monoclonal Antibodies Consumption Share by Types in 2021
-
Figure South China Cancer Monoclonal Antibodies Consumption Share by Types in 2027
-
Table South China Cancer Monoclonal Antibodies Consumption by End-Users from 2016 to 2027
-
Table South China Cancer Monoclonal Antibodies Consumption Share by End-Users from 2016 to 2027
-
Figure South China Cancer Monoclonal Antibodies Consumption Share by End-Users in 2016
-
Figure South China Cancer Monoclonal Antibodies Consumption Share by End-Users in 2021
-
Figure South China Cancer Monoclonal Antibodies Consumption Share by End-Users in 2027
-
Table East China Cancer Monoclonal Antibodies Consumption by Types from 2016 to 2027
-
Table East China Cancer Monoclonal Antibodies Consumption Share by Types from 2016 to 2027
-
Figure East China Cancer Monoclonal Antibodies Consumption Share by Types in 2016
-
Figure East China Cancer Monoclonal Antibodies Consumption Share by Types in 2021
-
Figure East China Cancer Monoclonal Antibodies Consumption Share by Types in 2027
-
Table East China Cancer Monoclonal Antibodies Consumption by End-Users from 2016 to 2027
-
Table East China Cancer Monoclonal Antibodies Consumption Share by End-Users from 2016 to 2027
-
Figure East China Cancer Monoclonal Antibodies Consumption Share by End-Users in 2016
-
Figure East China Cancer Monoclonal Antibodies Consumption Share by End-Users in 2021
-
Figure East China Cancer Monoclonal Antibodies Consumption Share by End-Users in 2027
-
Table Northeast China Cancer Monoclonal Antibodies Consumption by Types from 2016 to 2027
-
Table Northeast China Cancer Monoclonal Antibodies Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Cancer Monoclonal Antibodies Consumption Share by Types in 2016
-
Figure Northeast China Cancer Monoclonal Antibodies Consumption Share by Types in 2021
-
Figure Northeast China Cancer Monoclonal Antibodies Consumption Share by Types in 2027
-
Table Northeast China Cancer Monoclonal Antibodies Consumption by End-Users from 2016 to 2027
-
Table Northeast China Cancer Monoclonal Antibodies Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Cancer Monoclonal Antibodies Consumption Share by End-Users in 2016
-
Figure Northeast China Cancer Monoclonal Antibodies Consumption Share by End-Users in 2021
-
Figure Northeast China Cancer Monoclonal Antibodies Consumption Share by End-Users in 2027
-
Table Southwest China Cancer Monoclonal Antibodies Consumption by Types from 2016 to 2027
-
Table Southwest China Cancer Monoclonal Antibodies Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Cancer Monoclonal Antibodies Consumption Share by Types in 2016
-
Figure Southwest China Cancer Monoclonal Antibodies Consumption Share by Types in 2021
-
Figure Southwest China Cancer Monoclonal Antibodies Consumption Share by Types in 2027
-
Table Southwest China Cancer Monoclonal Antibodies Consumption by End-Users from 2016 to 2027
-
Table Southwest China Cancer Monoclonal Antibodies Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Cancer Monoclonal Antibodies Consumption Share by End-Users in 2016
-
Figure Southwest China Cancer Monoclonal Antibodies Consumption Share by End-Users in 2021
-
Figure Southwest China Cancer Monoclonal Antibodies Consumption Share by End-Users in 2027
-
Table Northwest China Cancer Monoclonal Antibodies Consumption by Types from 2016 to 2027
-
Table Northwest China Cancer Monoclonal Antibodies Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Cancer Monoclonal Antibodies Consumption Share by Types in 2016
-
Figure Northwest China Cancer Monoclonal Antibodies Consumption Share by Types in 2021
-
Figure Northwest China Cancer Monoclonal Antibodies Consumption Share by Types in 2027
-
Table Northwest China Cancer Monoclonal Antibodies Consumption by End-Users from 2016 to 2027
-
Table Northwest China Cancer Monoclonal Antibodies Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Cancer Monoclonal Antibodies Consumption Share by End-Users in 2016
-
Figure Northwest China Cancer Monoclonal Antibodies Consumption Share by End-Users in 2021
-
Figure Northwest China Cancer Monoclonal Antibodies Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Takeda Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Takeda Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Takeda Pharmaceuticals
-
Table Product and Service Introduction of Takeda Pharmaceuticals
-
Table Company Profile and Development Status of Bristol-Myers Squibb
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb
-
Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb
-
Figure Revenue and Market Share Analysis of Bristol-Myers Squibb
-
Table Product and Service Introduction of Bristol-Myers Squibb
-
Table Company Profile and Development Status of Amgen
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen
-
Figure Sales and Growth Rate Analysis of Amgen
-
Figure Revenue and Market Share Analysis of Amgen
-
Table Product and Service Introduction of Amgen
-
Table Company Profile and Development Status of F Hoffmann-La Roche
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche
-
Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche
-
Figure Revenue and Market Share Analysis of F Hoffmann-La Roche
-
Table Product and Service Introduction of F Hoffmann-La Roche
-
